10-Q: 3D Systems Reports Q3 2024 Results, Faces Significant Impairment Charges

3D Systems reported a net loss of $178.6 million for Q3 2024, impacted by significant asset impairment charges and a decrease in revenue.

Summary

• 3D Systems reported a net loss of $178.6 million for the third quarter of 2024, a significant increase from the $11.7 million loss in the same period last year.
• The company's revenue decreased by 8.8% to $112.9 million, with both product and service revenues experiencing declines.
• Gross profit decreased by 24.6% to $41.7 million, and the gross profit margin fell to 36.9%.
• Operating expenses surged to $222.5 million, primarily due to a $143.7 million asset impairment charge.
• The company's Adjusted EBITDA was negative $14.3 million, compared to a positive $4.7 million in the prior year period.
• For the nine months ended September 30, 2024, the net loss was $221.9 million, compared to a loss of $70.0 million in the same period of 2023.
• The company's revenue for the nine months ended September 30, 2024 decreased by 11.8% to $329.1 million.
• The company recorded a goodwill impairment charge of $101.4 million and other asset impairment charges of $42.3 million.
• The company's cash and cash equivalents decreased to $190 million from $331.5 million at the end of 2023.

Sentiment

Score: 2

Explanation: The document indicates a very negative sentiment due to significant losses, impairment charges, and declining revenue. The company is facing significant financial challenges and risks, and the outlook is uncertain.

Positives

• The company has substantially completed its in-sourcing activities related to its European metal printer operations.
• Actions taken to reduce headcount commenced during the year ended December 31, 2023 and were substantially completed during the three months ended September 30, 2024.
• The company has partially or fully exited 15 leased facilities as part of its plan to rationalize its geographic footprint.
• The company expects to have exited all facilities identified as part of its facilities rationalization plan by December 31, 2024.
• The company's cash used in operating activities decreased by $34.8 million for the nine months ended September 30, 2024, compared to the same period in 2023.

Negatives

• The company experienced a significant net loss of $178.6 million in Q3 2024.
• Revenue decreased by 8.8% to $112.9 million.
• Gross profit margin decreased to 36.9%.
• Operating expenses increased significantly to $222.5 million due to asset impairment charges.
• Adjusted EBITDA was negative $14.3 million.
• The company's cash and cash equivalents decreased to $190 million.
• The company's total revenue for the nine months ended September 30, 2024 decreased by 11.8% to $329.1 million.
• The company's net loss for the nine months ended September 30, 2024 was $221.9 million.

Risks

• The company's financial performance is subject to macroeconomic events, including recession, supply chain disruptions, inflation, interest rates and foreign exchange volatility.
• The company's ability to deliver products that meet changing technology and customer needs is a risk.
• The company's ability to identify strategic acquisitions, integrate them, and realize benefits is a risk.
• The company faces risks related to intellectual property rights, cyber-attacks, and product quality.
• The company's ability to generate net cash flow from operations is a risk.
• The company's ability to service its debt and raise funds is a risk.
• The company's ability to remediate material weaknesses in internal controls is a risk.
• The company is subject to fluctuations in gross profit margins, operating income or loss and/or net income or loss.
• The company's ability to efficiently conduct business outside the U.S. is a risk.
• The company is dependent on its supply chain for components and raw materials.
• The company faces risks related to litigation, investigations, and compliance with various laws and regulations.
• The company's ability to retain key employees and attract new qualified employees is a risk.
• The company's ability to successfully develop and commercialize regenerative medicine products is a risk.
• The company is no longer eligible to use a Form S-3 registration statement, which could impair its capital-raising activities.

Future Outlook

The company expects aggregate annualized cost savings from its 2023 Restructuring Plan to be between $45.0 and $55.0 million when completed. The company expects limited printer sales to its key customer in the dental industry for the remainder of 2024. The company expects that price/mix is expected to continue to have an unfavorable impact on its Health Solutions materials and total revenue for the remainder of the current year.

Industry Context

The results reflect challenges in the 3D printing industry, including macroeconomic pressures and shifts in customer demand. The company's focus on regenerative medicine and strategic acquisitions indicates an attempt to diversify and grow in new markets, but these efforts are still in early stages.

Comparison to Industry Standards

• The significant impairment charges and net losses reported by 3D Systems are worse than many of its competitors in the 3D printing industry, such as Stratasys and Desktop Metal, which have also faced challenges but have not reported such large losses.
• The decline in revenue and gross profit margin is also concerning when compared to industry benchmarks, indicating potential issues with pricing, product mix, or market demand.
• The company's cash burn rate is also higher than some of its peers, raising concerns about its long-term financial sustainability.
• The company's strategic shift towards regenerative medicine is a unique approach compared to other 3D printing companies, but it is still in the early stages and its success is uncertain.

Corporate Governance

Legal Proceedings

• The company is involved in derivative lawsuits pending in various courts.
• The company is cooperating with the SEC in connection with its formal investigation.
• The company is in non-binding mediation with the former owners of Volumetric regarding earnout payments.

Related Party Transactions

• The company's reported revenue and cost of sales for the three months ended September 30, 2024 includes related party revenue and associated related party cost of sales of $376 and $231, respectively, attributable to sales to NAMI.
• The company's reported revenue and cost of sales for the nine months ended September 30, 2024 includes related party revenue and associated related party cost of sales of $3,536 and $2,549, respectively, attributable to sales to NAMI.
• The company's reported revenue and cost of sales for the three months ended September 30, 2023 includes related party revenue and associated related party cost of sales of $865 and $579, respectively, attributable to sales to NAMI.
• The company's reported revenue and cost of sales for the nine months ended September 30, 2023 includes related party revenue and associated related party cost of sales of $1,215 and $770, respectively, attributable to sales to NAMI.
• As of September 30, 2024 and December 31, 2023, the outstanding related party receivable balances attributable to our sales to NAMI were $2,869 and $1,092, respectively.
• During the three and nine months ended September 30, 2024, the Company made purchases from Enhatch of $249 and $428, respectively.
• During the three and nine months ended September 30, 2023, the Company made purchases from Enhatch of $60 and $88, respectively.
• As of September 30, 2024 and December 31, 2023, the outstanding related party payable balances attributable to our purchases from Enhatch were $22 and $26, respectively.

Stakeholder Impact

• Shareholders are negatively impacted by the significant net loss and decline in stock price.
• Employees may be affected by the ongoing restructuring and potential future cost-cutting measures.
• Customers may experience changes in product availability and pricing due to the company's restructuring efforts.
• Suppliers may be impacted by changes in the company's purchasing patterns and potential renegotiation of contracts.
• Creditors may be concerned about the company's ability to service its debt given the significant losses and cash burn.

Next Steps

• The company expects to have exited all facilities identified as part of its facilities rationalization plan by December 31, 2024.
• The company is in the process of implementing certain changes to its internal controls to remediate the material weaknesses described in its 2023 Form 10-K.
• The company continues to evaluate strategic alternatives related to the remaining portion of Oqton MOS that the Company continues to hold.
• The company is continuing mediation with the former shareholders and key employees of Volumetric.

Key Dates

Keywords

3D printing, additive manufacturing, financial results, impairment, revenue, net loss, EBITDA, healthcare solutions, industrial solutions, restructuring, asset impairment, operating expenses